SCHEMBL13615711

SCHEMBL13615711

Cc1cc(C)cc(N(c2cc(C)cc(C)c2)c2ccc3c(-c4ccc(N(c5ccccc5)c5ccc6ccccc6c5)cc4)c4cc(N(c5cc(C)cc(C)c5)c5cc(C)cc(C)c5)ccc4c(-c4ccc(N(c5ccccc5)c5ccc6ccccc6c5)cc4)c3c2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 3/20 0.34
CYP2A6 P11509 1/20 0.34
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 3/20 0.33
CYP2C9 P11712 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
CYP2C19 P33261 2/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP2D6 P10635 1/20 0.33
LMNA P02545 2/20 0.32
NR1I2 O75469 1/20 0.32
MAPK1 P28482 1/20 0.32
HTR2B P41595 1/20 0.32
CYP51A1 Q16850 1/20 0.32
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15468224 0.95 IKBKB (0.35) L3MBTL1HTTNPSR1TDP1CYP2A6
SCHEMBL13333943 0.92 L3MBTL1 (0.37) L3MBTL1HTTNPSR1TDP1CYP2A6
SCHEMBL15762757 0.92 L3MBTL1 (0.42) L3MBTL1HTTNPSR1TDP1CYP2A6
SCHEMBL14516021 0.92 L3MBTL1 (0.39) L3MBTL1HTTNPSR1TDP1CYP2A6
SCHEMBL13333462 0.92 L3MBTL1 (0.42) L3MBTL1HTTNPSR1TDP1CYP2A6
SCHEMBL13615644 0.92 ALDH1A1 (0.39) L3MBTL1TDP1CYP1A2CYP3A4CYP2C9
SCHEMBL13333952 0.91 L3MBTL1 (0.36) L3MBTL1HTTNPSR1TDP1CYP2A6
SCHEMBL14099657 0.91 L3MBTL1 (0.41) L3MBTL1HTTNPSR1TDP1CYP2A6
SCHEMBL14099733 0.91 L3MBTL1 (0.41) L3MBTL1HTTNPSR1TDP1CYP2A6
SCHEMBL14516030 0.91 IKBKB (0.38) L3MBTL1HTTNPSR1TDP1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
EP-2103666-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, ORMDL3, CHRM2 L3MBTL1 283/4885HTT 2440/4885NPSR1 2689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.